1. CIP2A interacts with AKT1 to promote the malignant biological behaviors of oral squamous cell carcinoma by upregulating the GSK‑3β/β‑catenin pathway
   Yilei Che et al, 2023, Experimental and Therapeutic Medicine CrossRef
2. Predictive Biomarkers for Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer: A survey
   Hisham Abdeltawab et al, 2018, 2018 IEEE International Symposium on Signal Processing and Information Technology (ISSPIT) CrossRef
3. Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer
   Faping Li et al, 2020, Frontiers in Oncology CrossRef
4. Radiomics Analysis Based on Ultrasound Images to Distinguish the Tumor Stage and Pathological Grade of Bladder Cancer
   Rui‐zhi Gao et al, 2021, Journal of Ultrasound in Medicine CrossRef
5. Predictive Biomarkers for Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer: A survey
   Hisham Abdeltawab et al, 2018, 2018 IEEE International Symposium on Signal Processing and Information Technology (ISSPIT) CrossRef
6. Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
   Milad Ashrafizadeh et al, 2020, International Journal of Molecular Sciences CrossRef
7. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes
   Linhui Wang et al, 2021, Journal of Immunology Research CrossRef
8. Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma
   Rajab Alzahrani et al, 2020, Journal of Cancer Prevention CrossRef